BRCA2 and breast carcinoma: Today, women have a one in eight chance of developing breast cancer over their lifetime, a risk that is significantly increased if they have inherited harmful mutations in BRCA1 or BRCA2.1 However, breast cancer is a complex, heterogeneous disease characterized by a great multitude of aberrations at the genomic and molecular level, which can manifest in dysregulated signaling pathways.